Key result
During a foot-and-mouth disease outbreak on vaccinated dairy farms, incidence risk ranged from 2.6% to 20.1% and was higher among youngstock compared to adults.
Observational
Yes
Analysis of field data from FMD outbreaks provides a realistic estimation of expected vaccine performance and highlights the need to validate correlates of protection in field conditions.
Answers are grounded in this paper and cite their sources.
Variable FMD vaccine performance in outbreaks, higher in youngstock, warrants age-specific caution; leaves open validation of field correlates of protection.
In 2015, foot-and-mouth disease (FMD) viruses of the A/ASIA/G-VII lineage emerged from the Indian sub-continent to cause outbreaks in the Middle and Near East. A factor which has been proposed to have contributed to the rapid spread of this lineage is the poor in vitro vaccine-match of field isolates to vaccine strains that are commonly used in the region. This study used data from outbreaks on four large-scale dairy farms using routine vaccination in Saudi Arabia, to evaluate the impact of vaccination and learn how to manage outbreaks more effectively in this setting. This evaluation also included an assessment of vaccine-induced neutralisation titres to the vaccine and field strains on a related farm with no history of FMD that employed an identical vaccination schedule. The incidence risk among exposed groups ranged from 2.6 to 20.1% and was significantly higher among youngstock (18.7%) compared to adults (7.4%). Evidence was found that local isolation of individual sick animals was more effective than whole group isolation and that subclinical infection and undetected circulation may occur on large-scale farms in Saudi Arabia, although both of these points require further evaluation. On the unaffected farm, the mean reciprocal titres for the vaccine and field strains were all above the cut-off supposed to correlate with clinical protection based on evidence from challenge studies. An estimate of vaccination effectiveness was not possible on the affected farms, but the incidence of FMD provides a more realistic estimation of the expected vaccine performance than in vivo studies or r1 value as it is based on field conditions and natural exposure. This study shows that analysis of field data from FMD outbreaks are a useful addition to more conventional challenge and in vitro based evaluations of vaccines and suggests further work is necessary to validate correlates of protection in field conditions.
No takes yet. Share an insight, caveat, or question.
Lyons et al. (2017) conducted an observational in Foot-and-mouth disease. Polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 was evaluated on Incidence risk of foot-and-mouth disease. During a foot-and-mouth disease outbreak on vaccinated dairy farms, incidence risk ranged from 2.6% to 20.1% and was higher among youngstock compared to adults.
Synapse has enriched 10 related papers. Consider them for comparative context: